|
26 Aug 2025
|
Anlon Healthcare
|
Hem Securities
|
134.51
|
|
|
|
IPO Subscribe
|
|
|
Company is a chemical manufacturing company engaged in manufacturing of; (i) high purity advance pharmaceutical intermediates (Pharma Intermediate) which serves as raw material/ key starting material in the manufacturing of active pharmaceutical ingredients; and (ii) active pharmaceutical ingredients (APIs) which serves as a raw material for pharmaceutical formulations in preparation of various type of Finished Dosage Formula (FDF) such as tablet, capsules,...
|
|
25 Aug 2025
|
Anlon Healthcare
|
Ventura
|
134.51
|
|
|
|
IPO Subscribe
|
|
|
|